- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 17.12.24 | CTO Europe 2024: keep the burden of trials away from patients, say experts | ||
| 17.12.24 | ADCs breach barriers to become mainstream cancer treatment | ||
| 17.12.24 | GSK's lung cancer therapy gains EMA PRIME designation | ||
| 16.12.24 | FDA approves Galderma's Nemluvio to treat atopic dermatitis | ||
| 16.12.24 | The future of third-party logistics in an evolving biopharmaceutical world | ||
| 16.12.24 | Reprieve for WuXi as Biosecure vote likely pushed to 2025 | ||
| 16.12.24 | Small cell lung cancer: Navigating the global clinical trial landscape | ||
| 16.12.24 | EMA recommends expanding approval of Ofev to children and adolescents | ||
| 16.12.24 | Denmark's HTA evolution | ||
| 16.12.24 | EMA CHMP recommends Lilly's Crohn's therapy for EU approval | ||
| 16.12.24 | AbbVie to acquire Nimble Therapeutics for $200m | ||
| 13.12.24 | FDA accepts Sobi North America's thrombocytopenia therapy sNDA | ||
| 13.12.24 | Roche wins Vabysmo prefilled syringe EU approval to intensify Eylea challenge | ||
| 13.12.24 | Conduit and Sarborg link to optimise AI drug development | ||
| 13.12.24 | A novel, toothy approach to innovating randomization in clinical trials | ||
| 13.12.24 | AIM ImmunoTech gains Netherlands patent for post-Covid fatigue therapy | ||
| 13.12.24 | Flu vaccine strategy on the line as new US leaders anticipated to take charge | ||
| 12.12.24 | Nobel laureates 'strongly urge' Senate to oppose confirmation of RFK Jr | ||
| 12.12.24 | Building up the infrastructure for future pandemic preparedness: Frontiers in rapid raw material production | ||
| 12.12.24 | China NMPA approves Santhera's DMD treatment therapy | ||
| 12.12.24 | UK indefinitely bans puberty blockers for teenagers due to "unacceptable risk" | ||
| 12.12.24 | Meitheal gains US commercial rights for CABP treatment therapy | ||
| 12.12.24 | Transforming preventative care in the NHS | ||
| 12.12.24 | Sanofi's combo vaccines gain FDA fast track designation | ||
| 12.12.24 | How Pfizer management outplayed activist investor Starboard |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
